Summary
Background Healthcare-associated bacterial pathogens frequently carry plasmids that contribute to antibiotic resistance and virulence. The horizontal transfer of plasmids in healthcare settings has been previously documented, but genomic and epidemiologic methods to study this phenomenon remain underdeveloped. The objectives of this study were to develop a method to systematically resolve and track plasmids circulating in a single hospital, and to identify epidemiologic links that indicated likely horizontal plasmid transfer.
Methods We derived empirical thresholds of plasmid sequence similarity from comparisons of plasmids carried by bacterial isolates infecting individual patients over time, or involved in hospital outbreaks. We then applied those metrics to perform a systematic screen of 3,074 genomes of nosocomial bacterial isolates from a single hospital for the presence of 89 plasmids. We also collected and reviewed data from electronic health records for evidence of geotemporal associations between patients infected with bacteria encoding plasmids of interest.
Findings Our analyses determined that 95% of analyzed genomes maintained roughly 95% of their plasmid genetic content at a nucleotide identity at least 99·985%. Applying these similarity thresholds to identify horizontal plasmid transfer identified 45 plasmids circulating among clinical isolates. Ten plasmids met criteria for geotemporal links associated with horizontal transfer. Several plasmids with shared backbones also encoded different additional mobile genetic element content, and these elements were variably present among the sampled clinical isolate genomes.
Interpretation The horizontal transfer of plasmids among nosocomial bacterial pathogens is frequent within hospitals and can be monitored with whole genome sequencing and comparative genomics approaches. These approaches should incorporate both nucleotide identity and reference sequence coverage to study the dynamics of plasmid transfer in the hospital.
Funding This research was supported by the US National Institute of Allergy and Infectious Disease (NIAID) and the University of Pittsburgh School of Medicine.
Evidence before this study A search of PubMed for research articles containing the search terms “plasmid”, “transfer”, “epidemiology”, “hospital”, and “patients” identified 115 peer-reviewed manuscripts published before 01 January 2022. Twenty-four manuscripts documented the dissemination of one or more plasmids by horizontal transfer in a hospital setting. Most of these prior studies focused on a single plasmid, outbreak, antibiotic resistance gene or pathogen species, and none established an a priori approach to identify plasmids circulating among non-clonal bacterial genomes. While prior studies have quantified plasmid preservation and nucleotide identity, similarity thresholds to infer horizontal transfer were neither uniform across studies nor systematically derived from empirical data.
Added value of this study This study advances the field of genomic epidemiology by proposing and demonstrating the utility of empirically derived thresholds of plasmid sequence similarity for inferring horizontal transfer in healthcare settings. It also advances the field by tracking horizontal plasmid transfer within a single hospital at a hitherto unprecedented scale, examining the evidence of horizontal transfer of 89 plasmids among thousands of clinical bacterial isolates sampled from a single medical center. Our systematic review of patient healthcare data related to horizontal transfer also occurred at a breadth not previously undertaken in hospital epidemiology.
Implications of all the available evidence When successfully integrated into contemporary methods for surveillance of nosocomial pathogens, comparative genomics can be used to track and intervene directly against the dissemination of plasmids that exacerbate virulence and antimicrobial resistance in healthcare-associated bacterial infections. Standardized thresholds of plasmid identity benefit epidemiologic investigations of horizontal transfer similar to those offered by establishing uniform thresholds of genome identity for investigations of bacterial transmission.
Competing Interest Statement
Mr. Daniel Evans received compensation from the Allegheny County Health Department (Pittsburgh, PA, USA) for services rendered as an infectious disease epidemiologist while performing research and writing of this manuscript. Mr. Daniel Evans, Dr. Alexander Sundermann, and Dr. Mustapha M. Mustapha received compensation from EpiCenter Genomics LLC (Pittsburgh, PA, USA) for consulting services in genomic epidemiology. These entities did not provide funding directly towards the production of this manuscript, nor did they pay these authors for work contributing to its publication.
Funding Statement
This work was supported by NIAID grants R21Al109459 and R01AI127472 to Dr. Lee H. Harrison, U01AI124302 to Dr. Vaughn Cooper, and by the Department of Medicine at the University of Pittsburgh School of Medicine to Dr. Daria Van Tyne. Dr. Mustapha M. Mustapha was supported by grant KL2-TR001856. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study took place at the University of Pittsburgh Medical Center (UPMC) Presbyterian Hospital and the University of Pittsburgh School of Medicine. All bacterial isolates analyzed in this study were collected through the Enhanced Detection System for Hospital-Associated Transmission (EDS-HAT) project, using previously published eligibility criteria for selection of isolates. EDS-HAT uses a combination of WGS surveillance of selected hospital-associated pathogens and machine learning of the electronic health record to identify otherwise undetected outbreaks and the responsible transmission routes, respectively. The University of Pittsburgh Institutional Review Board (IRB) approved the EDS-HAT project and classified it as being exempt from informed consent because direct contact with human subjects is not performed. Approval was also granted (STUDY20060252) to use data collected for the EDS-HAT project to study the horizontal transfer of mobile genetic elements in the hospital.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Genome sequence data of all bacterial isolates studied here has been deposited in the Sequence Read Archive (SRA) with accession numbers listed in Appendix 1. Plasmid sequences included in this study have been deposited in GenBank with accession numbers listed in Appendix 2.
